Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

1.5K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
1.5K
Local Anesthetics: Differential Sensitivity of Nerve Fibers01:24

Local Anesthetics: Differential Sensitivity of Nerve Fibers

1.7K
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
1.7K
Analgesia and Pain Management01:25

Analgesia and Pain Management

3.2K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.2K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

1.7K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.7K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

1.5K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K
Bacterial Toxins01:12

Bacterial Toxins

97
Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
97

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Migraine and menopause as converging factors in brain vulnerability: a hypothesis-driven perspective.

The journal of headache and pain·2026
Same author

Opportunities and Concerns of Gamified, Extended Reality for Home-Based Motor Rehabilitation for Children With Brain Injury: Qualitative Case Study on Design Elements Related to the Engagement and Fatigue Perspectives.

Journal of medical Internet research·2026
Same author

Digital Twins in Neurology Care: Evidence, Limitations, and a Path Forward.

Journal of integrative neuroscience·2026
Same author

Menopause-related brain fog as a midlife window in women's brain aging: toward ecologically valid measurement and digital phenotyping.

Frontiers in human neuroscience·2026
Same author

Pharmacist-led migraine consultations in community pharmacies: a pilot study of pharmacists' experiences and patient-reported outcomes.

The journal of headache and pain·2026
Same author

Bridging digital health gaps in South Africa: A qualitative study of the digital divide, interoperability and health equity.

Digital health·2026

Related Experiment Video

Updated: Apr 17, 2026

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
10:25

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses

Published on: November 3, 2014

34.9K

Venom-based biotoxins as potential analgesics.

Parisa Gazerani1, Brian Edwin Cairns

  • 1Center for Sensory - Motor Interaction (SMI), Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Fredrik Bajers Vej 7D3, DK-9220 Aalborg East, Denmark.

Expert Review of Neurotherapeutics
|September 20, 2014
PubMed
Summary

Venom-derived biotoxins show promise for managing chronic pain by blocking pain signaling pathways. These natural compounds are being explored in clinical trials as novel analgesic therapies.

Keywords:
analgesicsbiotoxinion channelspaintoxinvenom

More Related Videos

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

10.2K
Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects
09:45

Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects

Published on: April 21, 2018

14.1K

Related Experiment Videos

Last Updated: Apr 17, 2026

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
10:25

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses

Published on: November 3, 2014

34.9K
Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

10.2K
Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects
09:45

Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects

Published on: April 21, 2018

14.1K

Area of Science:

  • Pharmacology
  • Neuroscience
  • Toxicology

Background:

  • Chronic pain is a widespread, debilitating condition with significant socioeconomic impact.
  • Current pain management strategies often fall short, leaving many patients with unsatisfactory outcomes.
  • Venom-derived biotoxins, particularly peptides, offer a unique approach to pain management.

Purpose of the Study:

  • To review venom-derived peptidergic biotoxins for chronic pain management.
  • To discuss their potential as analgesics and tools for pain research.
  • To highlight preclinical and clinical trial progress, challenges, and unmet needs.

Main Methods:

  • Literature review of venom-derived biotoxins.
  • Analysis of their mechanisms of action, focusing on ion channel blockade.
  • Examination of preclinical and clinical trial data.

Main Results:

  • Venom biotoxins effectively target key components of the pain signaling system, notably ion channels.
  • Several venom-derived peptides are in preclinical development or clinical trials for pain relief.
  • Preliminary in vitro studies show promising analgesic potential.

Conclusions:

  • Venom-derived peptidergic biotoxins represent a promising therapeutic avenue for chronic pain.
  • Further research and clinical trials are necessary to overcome challenges and meet unmet needs in pain management.
  • Biotoxins serve as valuable tools for understanding pain mechanisms and channelopathies.